A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...
More than 400 cartons of Nilotinib capsules were voluntarily recalled by Cipla USA after failing manufacturing specifications ...
LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...
Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic ...
Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Researchers have found evidence of nuclear metabolic enzymes for the first time, contributing to our understanding of cancer ...
WACO, Texas - Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier to ...
Fermented milk products and health effects The health benefits of consuming fermented milk products have been passed down through generations, without clearly understanding their full impact on human ...
Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism targeted by popular anti-aging supplements like nicotinamide mononucleotide ...
Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance. Emerging ...